Ontology highlight
ABSTRACT:
SUBMITTER: Wei SJ
PROVIDER: S-EPMC3835680 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
Wei Siau Jia SJ Joseph Thomas T Chee Sharon S Li Ling L Yurlova Larisa L Zolghadr Kourosh K Brown Christopher C Lane David D Verma Chandra C Ghadessy Farid F
PloS one 20131120 11
Pharmacological modulation of p53 activity is an attractive therapeutic strategy in cancers with wild-type p53. Presently in clinical trials, the small molecule Nutlin-3A competitively binds to HDM2, a key negative regulator of p53 and blocks its activity. We have described resistance mutations in HDM2 that selectively reduce affinity for Nutlin but not p53. In the present communication, we show that stapled peptides targeting the same region of HDM2 as Nutlin are refractory to these mutations, ...[more]